LakeShore Biopharma Co., Ltd. SCHEDULE 13D/A
SCHEDULE 13D/A · Crystal Peak Investment Inc. · Filed Oct 29, 2025
Documents
- SCHEDULEprimary_doc.xml
- EX-99.1
EXECUTIVE OFFICERS AND DIRECTORS
- EX-99.2
JOINT FILING AGREEMENT DATED OCTOBER 29, 2025 BY AND AMONG THE REPORTING PERSONS
- EX-99.3
PROPOSAL DATED AUGUST 18, 2025 FROM OCEANPINE TO THE BOARD OF DIRECTORS OF THE ISSUER
- EX-99.4
CONSORTIUM AGREEMENT DATED AUGUST 26, 2025 BY AND AMONG OCEANPINE INVESTMENT, OCEANPINE CAPITAL, AND CRYSTAL INVESTMENT
- EX-99.5
REVISED PROPOSAL DATED AUGUST 26, 2025 FROM OCEANPINE AND CRYSTAL INVESTMENT TO THE BOARD OF DIRECTORS OF THE ISSUER
- EX-99.6
DEED OF ADHERENCE BY ADJUVANT FUND AND ADJUVANT FUND DE DATED OCTOBER 5, 2025
- EX-99.7
DEED OF ADHERENCE BY SUPERSTRING CAPITAL DATED OCTOBER 27, 2025
- EX-99.8
DEED OF ADHERENCE BY MSA GROWTH DATED OCTOBER 27, 2025
- EX-99.9
DEED OF ADHERENCE BY EPIPHRON CAPITAL DATED OCTOBER 27, 2025